[go: up one dir, main page]

TR201103752A2 - Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. - Google Patents

Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.

Info

Publication number
TR201103752A2
TR201103752A2 TR2011/03752A TR201103752A TR201103752A2 TR 201103752 A2 TR201103752 A2 TR 201103752A2 TR 2011/03752 A TR2011/03752 A TR 2011/03752A TR 201103752 A TR201103752 A TR 201103752A TR 201103752 A2 TR201103752 A2 TR 201103752A2
Authority
TR
Turkey
Prior art keywords
thiocolchicoside
lansoprazole
diclofenac
combinations
pharmaceutically acceptable
Prior art date
Application number
TR2011/03752A
Other languages
English (en)
Inventor
Mustafa İskender Pi̇sak İbrahi̇m
Bi̇ngöl Semra
Levent Selamoğlu Mehmet
Original Assignee
Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. filed Critical Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş.
Priority to TR2011/03752A priority Critical patent/TR201103752A2/tr
Priority to PCT/TR2012/000060 priority patent/WO2012144964A1/en
Publication of TR201103752A2 publication Critical patent/TR201103752A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş; kas gevşetici olarak tiyokolşikozit ya da farmasötik olarak kabul edilebilir bir tuzunu, non-steroidal anti-enflamatuar ilaç olarak diklofenak ya da farmasötik olarak kabul edilebilir bir tuzunu; ve mide koruyucu ilaç olarak lansoprazol ya da farmasötik olarak kabul edilebilir bir tuzunu içeren birim dozaj formlarına ilişkindir.
TR2011/03752A 2011-04-18 2011-04-18 Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları. TR201103752A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/03752A TR201103752A2 (tr) 2011-04-18 2011-04-18 Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.
PCT/TR2012/000060 WO2012144964A1 (en) 2011-04-18 2012-04-18 Thiocolchicoside, diclofenac and lansoprazole combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/03752A TR201103752A2 (tr) 2011-04-18 2011-04-18 Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.

Publications (1)

Publication Number Publication Date
TR201103752A2 true TR201103752A2 (tr) 2012-11-21

Family

ID=46246160

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/03752A TR201103752A2 (tr) 2011-04-18 2011-04-18 Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.

Country Status (2)

Country Link
TR (1) TR201103752A2 (tr)
WO (1) WO2012144964A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2848260T3 (pl) * 2013-09-12 2016-09-30 Nowe formulacje tiokolchikozydu
EP2848259B1 (en) * 2013-09-12 2016-03-23 Sanovel Ilac Sanayi ve Ticaret A.S. Sustained release pharmaceutical formulations of Thiocolchicoside
PL2848261T3 (pl) * 2013-09-12 2016-10-31 Formulacje farmaceutyczne zawierające kombinację zwiotczającą mięśnie i przeciwbólową
WO2016001133A1 (en) * 2014-06-30 2016-01-07 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
EP3236952B1 (en) * 2014-12-23 2019-07-03 KRKA, d.d., Novo mesto Pharmaceutical tablet composition
WO2017084680A1 (en) * 2015-11-17 2017-05-26 Rontis Hellas S.A. Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
TR201717134A2 (tr) * 2016-12-07 2018-07-23 Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi Ağrı Ve Enflamasyonun Hızlı Tedavisi İçin Diklofenak Ve H2 Reseptör Antagonistlerinin Çabuk Salımlı Oral Kombinasyonları

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725134B1 (fr) 1994-10-04 1996-12-20 Lederle Lab Nouvelle association pharmaceutique a base d'ibuprofene et de thiocolchicoside
FR2735369B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
PT1411900E (pt) 2001-06-01 2010-10-11 Pozen Inc Composições farmacêuticas para a entrega coordenada de aines
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
US20050249806A1 (en) 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
EP2063873A2 (en) * 2006-08-31 2009-06-03 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
TR200703092A1 (tr) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen ve kas gevşetici kombinasyonları
FR2926723B1 (fr) * 2008-01-25 2010-06-18 Duo Ge Associations pharmaceutiques orales.
US20090233970A1 (en) 2008-03-11 2009-09-17 Nickell Robert P Combined nsaid and acid blocker formulation and method
BRPI0924198A2 (pt) 2009-01-22 2016-02-16 Sanofi Sa combinação de ingredientes ativos contendo um fármaco anti-inflamtório não esteroidal e um derivado de colchicosida

Also Published As

Publication number Publication date
WO2012144964A1 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CY1121625T1 (el) Αναστολεις prmt5 και χρησεις αυτων
CY1119167T1 (el) Αναστολεις toy nkcc για τη θεραπεια του αυτισμου
TR201103752A2 (tr) Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
CY1116645T1 (el) Ενωση-αναστολεας σηματοδοτικου μονοπατιου notch
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
EA201491607A1 (ru) Модуляторы толлподобных рецепторов
EA201070786A1 (ru) Бензофуропиримидиноны
EA201391615A1 (ru) Дейтерированные потенциаторы cftr
MY163083A (en) Solid forms of a pharmaceutically active substance
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
BR112014010631A2 (pt) inibidores de pak para o tratamento da síndrome do x frágil
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
MX375926B (es) Compuestos y metodos para inhibir el transporte de fosfato.
EA201001710A2 (ru) Фармацевтическая композиция, которая содержит соль стронция, витамин d и циклодекстрин
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
CY1121999T1 (el) Φαρμακοτεχνικες μορφες συνδυασμου δαρουναβιρης
BR112013023266A8 (pt) Inibidores da girase tricíclicos
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
EA201190125A1 (ru) Таблетки для комбинированной терапии